264
Participants
Start Date
January 31, 2014
Primary Completion Date
February 28, 2015
Study Completion Date
March 31, 2015
LBR-101 High Dose
Subcutaneously Administered LBR-101 Monthly x 3
LBR-101 Low Dose
Subcutaneously Administered LBR-101 Monthly x 3
Placebo
Subcutaneously Administered Placebo (Vehicle) Monthly x 3
Teva Investigational Site 105, The Bronx
Teva Investigational Site 111, Philadelphia
Teva Investigational Site 123, Charlottesville
Teva Investigational Site 144, Roanoke
Teva Investigational Site 168, Winston-Salem
Teva Investigational Site 118, Raleigh
Teva Investigational Site 120, Goose Creek
Teva Investigational Site 164, Decatur
Teva Investigational Site 134, Douglasville
Teva Investigational Site 149, Atlanta
Teva Investigational Site 140, Port Orange
Teva Investigational Site 139, Ormond Beach
Teva Investigational Site 101, Jacksonville
Teva Investigational Site 166, Jacksonville
Teva Investigational Site 143, DeLand
Teva Investigational Site 129, Maitland
Teva Investigational Site 167, Orlando
Teva Investigational Site 137, Hialeah
Teva Investigational Site 154, Nashville
Teva Investigational Site 153, Bristol
Teva Investigational Site 126, Memphis
Teva Investigational Site 102, Columbus
Teva Investigational Site 155, Cleveland
Teva Investigational Site 122, Canton
Teva Investigational Site 141, Cincinnati
Teva Investigational Site 125, Evansville
Teva Investigational Site 110, Ann Arbor
Teva Investigational Site 114, Kalamazoo
Teva Investigational Site 150, Golden Valley
Teva Investigational Site 104, St Louis
Teva Investigational Site 152, Kansas City
Teva Investigational Site 107, Springfield
Teva Investigational Site 133, Lenexa
Teva Investigational Site 127, Oklahoma City
Teva Investigational Site 128, Arlington
Teva Investigational Site 121, Austin
Teva Investigational Site 136, Austin
Teva Investigational Site 132, Boulder
Teva Investigational Site 130, Phoenix
Teva Investigational Site 145, Gilbert
Teva Investigational Site 117, Scottsdale
Teva Investigational Site 148, Reno
Teva Investigational Site 119, Long Beach
Teva Investigational Site 146, Oceanside
Teva Investigational Site 161, Anaheim
Teva Investigational Site 116, Fullerton
Teva Investigational Site 113, San Francisco
Teva Investigational Site 108, Stanford
Teva Investigational Site 112, Walnut Creek
Teva Investigational Site 162, Stamford
Teva Investigational Site 135, Brockton
Teva Investigational Site 124, New Bedford
Teva Investigational Site 151, Springfield
Teva Investigational Site 109, Watertown
Teva Investigational Site 115, Worcester
Teva Investigational Site 131, Greensboro
Teva Investigational Site 142, Cincinnati
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY